PLYMOUTH, Minn.--(BUSINESS WIRE)--Interrad Medical, a privately held medical device company, announces the SecurAcath Subcutaneous Engineered Stabilization Device is now recommended by the National ...
PLYMOUTH, Minn.--(BUSINESS WIRE)--Interrad Medical, a privately held medical device company, announces the SecurAcath Subcutaneous Catheter Securement Device has been selected for the Innovation and ...
The company identified 3 published economic studies, but the external assessment centre considered them to be outside the scope. It did not identify any further economic studies. The company presented ...
PLYMOUTH, Minn.--(BUSINESS WIRE)--Interrad Medical, a privately held medical device company, announces its SecurAcath device has received an Innovative Technology contract from Vizient, Inc., the ...
Interrad Medical, Inc. a privately held medical device company, announced today that it has raised approximately $10 million in its Series C financing. The funding was raised through a private ...
A new study on securement for central vascular access devices (CVAD) suggests that subcutaneous anchor securement systems (SASS) are shown to be more effective at keeping central catheters in place, ...
BLOOMINGTON, Ind.--The largest study of patients with peripherally inserted central catheters (PICC) utilizing a subcutaneous anchoring securement system (SASS) ever conducted shows that using ...
FERNDALE, Mich. -- A new study on securement for central vascular access devices (CVAD) suggests that subcutaneous anchor securement systems (SASS) are shown to be more effective at keeping central ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results